Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Managing GERD in Elderly Patients

Initial Pharmacologic Approach

  • The American Gastroenterological Association recommends starting with a 4-8 week trial of single-dose PPI (omeprazole 20 mg) taken 30-60 minutes before breakfast, while continuing SSRIs like escitalopram, as they do not contraindicate standard GERD management and may serve as neuromodulators if functional esophageal disorder is present 1, 2
  • Begin omeprazole 20 mg once daily, taken 30-60 minutes before the first meal of the day for optimal acid suppression, and escalate to twice-daily dosing if inadequate response after 4 weeks 1, 2, 3
  • Continue SSRIs without modification, as there is no contraindication to concurrent use with PPIs, and emphasize to the patient that PPIs are safe for treatment of GERD, with safety profiles comparable to placebo for short-term use 1, 2, 4

Concurrent Lifestyle Modifications

  • Implement age-appropriate modifications, including weight loss if overweight or obese, which has the strongest evidence for efficacy in GERD management 2
  • Elevate the head of bed 6-8 inches for nighttime symptoms or regurgitation, particularly important in elderly patients who may have delayed gastric emptying 2, 4
  • Avoid lying down for 2-3 hours after meals to reduce reflux episodes, and consider small, frequent meals rather than large meals, which is especially helpful in older adults 2, 4

Assessment and Dose Optimization

  • Reassess at 4-8 weeks to determine treatment response, and if symptoms resolve, taper to the lowest effective dose that maintains symptom control 1, 2, 3
  • For breakthrough symptoms despite PPI therapy, add alginate antacids for rapid relief, and for nighttime symptoms specifically, consider adding bedtime H2RA (famotidine) 1, 2

Special Considerations for Elderly Patients

  • In elderly patients without confirmed erosive disease or Barrett's esophagus who have normal acid exposure on pH testing, the symptoms may represent functional heartburn or esophageal hypersensitivity rather than true GERD, and the SSRI is actually beneficial as neuromodulation therapy, and PPI can be tapered off as tolerated 1, 2
  • If long-term PPI therapy (>12 months) is required, periodically reassess the need and attempt to use the lowest effective dose, and for confirmed severe GERD or erosive esophagitis, long-term PPI therapy is generally required and benefits outweigh risks 1, 2, 4

REFERENCES

2

Management of Gastroesophageal Reflux Disease (GERD) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Initial Treatment Approach for GERD vs. Peptic Ulcers [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Management of Esophageal Food Retention and GERD Symptoms [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025